Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial

Journals

1. Manchanda R, Gaba F. Population Based Testing for Primary Prevention: A Systematic Review. Cancers 2018;10(11):424 View
2. Toro-Huamanchumo C, Burgos-Muñoz S, Vargas-Tineo L, Perez-Fernandez J, Vargas-Tineo O, Burgos-Muñoz R, Zentner-Guevara J, Bada C. Awareness, behavior and attitudes concerning sun exposure among beachgoers in the northern coast of Peru. PeerJ 2019;7:e6189 View
3. Aspinwall L, Stump T, Taber J, Drummond D, Kohlmann W, Champine M, Leachman S. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk. Translational Behavioral Medicine 2018;8(1):29 View
4. Hay J, Zielaskowski K, Meyer White K, Kaphingst K, Robers E, Guest D, Sussman A, Talamantes Y, Schwartz M, Rodríguez V, Li Y, Schofield E, Bigney J, Hunley K, Buller D, Berwick M. Interest and Uptake ofMC1RTesting for Melanoma Risk in a Diverse Primary Care Population. JAMA Dermatology 2018;154(6):684 View
5. Cust A, Mishra K, Berwick M. Melanoma–role of the environment and genetics. Photochemical & Photobiological Sciences 2018;17(12):1853 View
6. Turbitt E, Roberts M, Hollister B, Lewis K, Biesecker L, Klein W. Ethnic identity and engagement with genome sequencing research. Genetics in Medicine 2019;21(8):1735 View
7. Smit A, Collazo-Roman M, Vadaparampil S, Valavanis S, Del Rio J, Soto B, Flores I, Dutil J, Kanetsky P. MC1R variants and associations with pigmentation characteristics and genetic ancestry in a Hispanic, predominately Puerto Rican, population. Scientific Reports 2020;10(1) View
8. Kaphingst K, Khan E, White K, Sussman A, Guest D, Schofield E, Dailey Y, Robers E, Schwartz M, Li Y, Buller D, Hunley K, Berwick M, Hay J. Effects of health literacy skills, educational attainment, and level of melanoma risk on responses to personalized genomic testing. Patient Education and Counseling 2021;104(1):12 View
9. Kanetsky P, Hay J. Marshaling the Translational Potential ofMC1Rfor Precision Risk Assessment of Melanoma. Cancer Prevention Research 2018;11(3):121 View
10. White K, Dailey Y, Guest D, Zielaskowski K, Robers E, Sussman A, Hunley K, Hughes C, Schwartz M, Kaphingst K, Buller D, Hay J, Berwick M. MC1RVariation in a New Mexico Population. Cancer Epidemiology, Biomarkers & Prevention 2019;28(11):1853 View
11. Lacson J, Doyle S, Qian L, Del Rio J, Forgas S, Valavanis S, Carvajal R, Gonzalez-Calderon G, Kim Y, Roetzheim R, Sutton S, Vadaparampil S, Kanetsky P. A Randomized Trial of Precision Prevention Materials to Improve Primary and Secondary Melanoma Prevention Activities among Individuals with Limited Melanoma Risk Phenotypes. Cancers 2021;13(13):3143 View
12. Hay J, Kaphingst K, Buller D, Schofield E, Meyer White K, Sussman A, Guest D, Dailey Y, Robers E, Schwartz M, Li Y, Hunley K, Berwick M. Behavioral and Psychological Outcomes Associated with Skin Cancer Genetic Testing in Albuquerque Primary Care. Cancers 2021;13(16):4053 View
13. Hay J, Meyer White K, Sussman A, Kaphingst K, Guest D, Schofield E, Dailey Y, Robers E, Schwartz M, Zielaskowski K, Li Y, Buller D, Hunley K, Berwick M. Psychosocial and Cultural Determinants of Interest and Uptake of Skin Cancer Genetic Testing in Diverse Primary Care. Public Health Genomics 2019;22(1-2):58 View
14. Hamilton J, Genoff Garzon M, Shah I, Cadet K, Shuk E, Westerman J, Hay J, Offit K, Robson M. Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel <b><i>BRCA1/2</i></b> Genetic Risk Modifier Test. Public Health Genomics 2020;23(1-2):6 View
15. Lacson J, Kim Y, Roetzheim R, Sutton S, Vadaparampil S, Kanetsky P. Predictors of genetic risk recall among the participants of a randomized controlled precision prevention trial against melanoma. Genetics in Medicine 2023;25(4):100005 View
16. Lacson J, Doyle S, Del Rio J, Forgas S, Carvajal R, Gonzalez-Calderon G, Ramírez Feliciano A, Kim Y, Roetzheim R, Sutton S, Vadaparampil S, Soto-Torres B, Kanetsky P. A Randomized Clinical Trial of Precision Prevention Materials IncorporatingMC1RGenetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics. Cancer Research Communications 2022;2(1):28 View
17. Banerjee S, Sussman A, Schofield E, Guest D, Dailey Y, Schwartz M, Buller D, Hunley K, Kaphingst K, Berwick M, Hay J. “Let’s Talk about Skin Cancer”: Examining Association between Family Communication about Skin Cancer, Perceived Risk, and Sun Protection Behaviors. Journal of Health Communication 2021;26(8):576 View
18. Lacson J, Forgas S, Doyle S, Qian L, Del Rio J, Valavanis S, Carvajal R, Gonzalez-Calderon G, Kim Y, Roetzheim R, Vadaparampil S, Kanetsky P. Assessment of melanoma precision prevention materials incorporating MC1R genetic risk information. Translational Behavioral Medicine 2022;12(5):683 View
19. Upshaw S, Jensen J, Giorgi E, Pokharel M, Lillie H, Adams D, John K, Wu Y, Grossman D. Developing skin cancer education materials for darker skin populations: crowdsourced design, message targeting, and acral lentiginous melanoma. Journal of Behavioral Medicine 2023;46(3):377 View
20. Cust A, Mishra K, Berwick M. Melanoma–role of the environment and genetics. Photochemical & Photobiological Sciences 2018;17(12):1853 View
21. Calderon-Casellas C, Lacson J, Forgas S, Doyle S, Del Rio J, Feliciano A, Kim Y, Roetzheim R, Sutton S, Vadaparampil S, Soto-Torres B, Kanetsky P. Assessment of skin cancer precision prevention materials among Hispanics in Florida and Puerto Rico. Patient Education and Counseling 2022;105(10):3143 View
22. Khan E, Kaphingst K, Meyer White K, Sussman A, Guest D, Schofield E, Dailey Y, Robers E, Schwartz M, Li Y, Buller D, Hunley K, Berwick M, Hay J. Comprehension of skin cancer genetic risk feedback in primary care patients. Journal of Community Genetics 2022;13(1):113 View
23. Hay J, Lee E, Christian S, Schofield E, Hamilton J, Yang C, Hedayati B, Sadeghi K, Robson M, Halpern A, Zhang L, Orlow I, Ahmad N. Interest and Utility of MC1R Testing for Melanoma Risk in Dermatology Patients with a History of Nonmelanoma Skin Cancer. Journal of Skin Cancer 2022;2022:1 View
24. Riley K, Sussman A, Schofield E, Guest D, Dailey Y, Schwartz M, Buller D, Hunley K, Kaphingst K, Berwick M, Hay J. Effect of Superstitious Beliefs and Risk Intuitions on Genetic Test Decisions. Medical Decision Making 2022;42(3):398 View
25. Rivera Rivera J, Lacson J, Kim Y, Roetzheim R, Sutton S, Soto-Torres B, Vadaparampil S, Kanetsky P. Sharing and seeking information about skin cancer risk and prevention among Hispanic people from Florida and Puerto Rico. PEC Innovation 2023;3:100232 View
26. Lacson J, Sutton S, Kim Y, Roetzheim R, Vadaparampil S, Soto-Torres B, Kanetsky P. Predictors of correct recall of genetic risk information among Hispanic individuals in Florida and Puerto Rico. Patient Education and Counseling 2023;117:107978 View
27. Lacson J, Soto-Torres B, Sutton S, Doyle S, Kim Y, Roetzheim R, Vadaparampil S, Kanetsky P. Skin cancer prevention behaviors, beliefs, distress, and worry among hispanics in Florida and Puerto Rico. BMC Public Health 2023;23(1) View
28. Hay J, Wu Y, Schofield E, Kaphingst K, Sussman A, Guest D, Hunley K, Li Y, Buller D, Berwick M. Exploring the role of cancer fatalism and engagement with skin cancer genetic information in diverse primary care patients. Psycho-Oncology 2024;33(4) View

Books/Policy Documents

1. Ginsburg G, Haga S. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics. View